RTX's Raytheon awarded $1.1 billion U.S. Navy contract to produce AIM-9X Block II missiles
Award continues program expansion capacity to meet rising domestic and international demand
Under the contract, Raytheon will produce AIM-9X missiles along with associated hardware and software for
"Our teams have streamlined production, shortened lead times and ramped up deliveries of AIM-9X missiles to keep pace with growing demand," said
AIM-9X is the most advanced infrared tracking, short-range air-to-air and surface-to-air missile, and it is combat-proven in multiple theaters around the world. The system is configured for easy installation on a wide range of modern aircraft and provides layered defense options with ground launched capabilities, including the National Advanced Surface to Air Missile System (NASAMS).
Trusted by the
A majority of the work under this contract will take place in
About Raytheon
Raytheon, an RTX business, is a leading provider of defense solutions to help the
About RTX
With more than 180,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. With industry-leading capabilities, we advance aviation, engineer integrated defense systems for operational success, and develop next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2025 sales of more than $88 billion, is headquartered in Arlington, Virginia.
For questions or to schedule an interview, please contact [email protected].
View original content:https://www.prnewswire.com/news-releases/rtxs-raytheon-awarded-1-1-billion-us-navy-contract-to-produce-aim-9x-block-ii-missiles-302811401.html
SOURCE RTX
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alibaba's Amap Unveils Full-Stack ABot Upgrade for Embodied AI Robots
- BC Token Hits $0.02, Setting a New All-Time High
- Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share